|
Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer Clinical research trials and Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer. Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer clinical trial. Participants oftentimes recieve the finest healthcare available for their Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "U" Clinical Trials Conditions > Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer  Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer
Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer
For Condition: Carcinoma, Non-Small-Cell Lung
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) ,
Synopsis: This is a research study for patients with inoperable lung cancer called non-small cell lung cancer (NSCLC). Currently, the information from a radiological test, computed tomography (CT) scan of the chest, is used to design the best arrangement of radiation beams which will kill tumor cells and still spare the normal parts of lungs and other normal organs in the chest. The purpose of this study is to explore whether adding information from another radiological test, called positron emission tomography (PET), will improve the accuracy of the radiation beam arrangement designed to treat lung cancer. A PET scan is a way to picture the biochemistry of tissues and organs: of how tissues in the body take up glucose, a normal nutrient of the body. The researchers will attempt to create radiation treatment plans from PET images alone and compare differences between hypothetical plans and standard-of-care CT-based radiation treatment plans. Because there is honest uncertainty about the contribution of PET to radiation treatment planning, it is possible that there will be no difference between a CT-based treatment plan and one resulting from PET information. It is also possible that the addition of PET may result in a radiation beam arrangement that may better control lung cancer. The addition of PET may also result in treating less normal tissues, which may lower the risk of radiation side effects. This study will provide the preliminary data necessary to design a larger clinical trial that may define the role of PET in radiation treatment planning.
Details:
Eligibility:
Study Type: Interventional, Treatment, Open Label
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Histologically confirmed locally advanced NSCLC (squamous, large cell undifferentiated or adenocarcinoma). - Disease limited to the thorax, adjacent mediastinum and neurovascular structures, and supraclavicular or scalene lymph node area, as defined by the AJCC Staging System. This includes patients with Stage IIIA and IIIB disease. - Performance status of 0-2 by Southwest Oncology Group criteria. - Medically inoperable patients (Stage I or II) - Locoregional recurrent tumor following surgery will be eligible provided they meet other eligibility criteria.
Total Enrollment:
Location and Contact Information:
UH B2 C490 Box 0010 E. Medical Center Drive
Ann Arbor, Michigan, 48109
United States
Additional Information:
Study ID Numbers: NCRR-M01RR00042-1662; M01RR00042
Study Start Date:
Record last reviewed: November 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005666
Other Carcinoma, Non-Small-Cell Lung Studies:
1. Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer
2. Iressa Expanded Access Program (EAP)
3. A Phase 3 Randomized Study of Lonafarnib in Combination With Paclitaxel and Carboplatin vs. Placebo in Combination with Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer
4. A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin versus Gemcitabine and Cisplatin in Patients with Advanced, Previously Untreated Non-Small Cell Lung Cancer
5. ZD6474 Alone or in Combination with Paclitaxel and Carboplatin in Subjects with Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Related Studies:
Other Carcinoma, Non-Small-Cell Lung Clinical Trials
Other Michigan Clinical Trials
Other Ann Arbor Clinical Trials
Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer
|
|
|
|
|
|
|
|
